跳至主要内容
临床试验/NCT03427879
NCT03427879已完成1 期

Effect of Flavonoids on Gut Permeability in Cyclists

Utah State University1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2018年9月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
12
试验地点
1
主要终点
Urinary lactulose:mannitol ratio by gas chromatography

研究概览

简要总结

The purpose of this investigation is to test the hypothesis that chronic supplementation with a dairy-based beverage containing a mixture of blueberry, green tea, and cocoa flavonoids (non-nutritive natural plant compounds) will ameliorate exercise-related changes in gut permeability and inflammation. In a previous feeding study in humans, (NCT02728570) a high flavonoid diet (flavonoids at 340 mg/1000kcal) was effective in mitigating gut permeability and inflammation in overweight and obese adults compared to a low flavonoid diet (10mg/1000 kcal). To test this hypothesis, 20 trained cyclists will complete a randomized crossover study with supplementation for 2 weeks with a dairy-based sports beverage containing either a high flavonoid (approximately 620 mg) or low flavonoid (approximately 5mg) beverage. After the two week intervention, cyclists will complete a 1 hour cycling trial (45 min at 65% VO2 max then 15 minute time trial). The primary endpoints will be gut permeability as measured by plasma intestinal fatty acid binding protein (I-FABP) and the differential sugar test. Secondary endpoints will include gut inflammation (measured via fecal calprotectin), plasma cytokines (IL-6, IL-10 and TNFα) and plasma LPS. In addition, the distance completed in the time trial is a secondary endpoint.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 49 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female of any race or ethnicity between 18 to 49 years of age
  • Competed in a road race or triathlon in past 12 months
  • Free of chronic disease and GI conditions
  • Train at least 3 times per week, 1 hour at a time on average
  • Willing to prepare and consume provided pre-workout beverage daily
  • Maintain weight (no more/less than 5 kg change)
  • Willing to avoid consumption of high flavonoid foods/supplements, large dose vitamin and mineral supplements, and NSAIDs or other medications known to affect inflammation during study period
  • Willing to provide urine, stool, and blood samples

排除标准

  • Age <18 or >50 years
  • Medical history of heart disease, hypertension, diabetes, Crohn's disease, IBS, colitis, celiac disease, inflammatory or autoimmune disease, and lactose intolerance
  • Uncontrolled hypertension: diastolic blood pressure >95 mm Hg or systolic blood pressure >160 mm Hg
  • For women: pregnancy, breast feeding or postpartum <6 months
  • Food allergies or restrictions to treatment/placebo beverages
  • Chronic use of NSAIDs
  • Consumption of flavonoid supplements <1 month prior to study start
  • Antibiotic use <3 months prior to study start
  • Other conditions (medical, psychiatric, or behavioral) that may present a safety hazard to the participant or interfere with study participation, as determined by the principal investigators

研究组 & 干预措施

Low flavonoid beverage

Placebo Comparator

Subjects will consume 310 milliliters per day of a dairy-based, low flavonoid, sports nutrition recovery beverage 14 days.

干预措施: Low flavonoid beverage (Drug)

High flavonoid beverage

Active Comparator

Subjects will consume 310 milliliters per day of a dairy-based, high flavonoid, sports nutrition recovery beverage 14 days.

干预措施: High flavonoid beverage (Drug)

结局指标

主要结局

Urinary lactulose:mannitol ratio by gas chromatography

时间窗: Three weeks

Measure of gut permeability from mouth to end of small intestine. Ratio of urinary lactulose to mannitol after subject consumes a beverage containing these sugars. Sugars in urine are measured by gas chromatography with flame ionization detection.

Plasma intestinal fatty acid binding protein (i-FABP) by ELISA

时间窗: Three weeks

Marker of gut wall integrity. i-FABP is measure by enzyme-linked immunosorbent assay in plasma of subjects after the time trial.

次要结局

  • Serum soluble interleukin-10 by ELISA(Three weeks)
  • Rating of perceived exertion by questionnaire.(One Day)
  • Fecal calprotectin by ELISA(Three weeks)
  • Urinary sucralose:mannitol ratio by gas chromatography(Three weeks)
  • Serum soluble tumor necrosis factor (TNFa) by ELISA(Three weeks)
  • Serum soluble interleukin-6 (IL-6) by ELISA(Three weeks)
  • Distance ridden in time trial(One Day)
  • Serum endotoxin by ELISA.(Three weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Ward

Associate Professor

Utah State University

研究点 (1)

Loading locations...

相似试验